已收录 273506 条政策
 政策提纲
  • 暂无提纲
Differential Effect of Benexate Hydrochloride Betadex on Prostaglandin Levels in Stomach and Inflammatory Site in Rats
[摘要] References(31)Cited-By(2)We compared the effects of an anti-ulcer agent, benexate hydrochloride betadex (BHB), on prostaglandin (PG) levels in gastric tissue and inflammatory exudate in untreated and indomethacintreated rats. BHB (100, 300 and 1000 mg/kg, p. o.) showed dose-dependent inhibition of gastric mucosal lesions induced by indomethacin (30 mg/kg, p. o.). Sustained decrease of PGS (PGE2 and 6-keto-PGF1α) in the gastric wall was observed from 0.5 to 6 hr after indomethacin treatment. BHB (300 and 1000 mg/kg) dose-dependently led to recovery of the indomethacin-induced decrease of gastric PGS at 1 and 6 hr after dosing. It did not antagonize the indomethacin-induced decrease of PG levels in the pleural exudate of carrageenin pleurisy nor did it affect the anti-inflammatory effects of indomethacin. BHB (100 to 1000 mg/kg) alone increased gastric PGE2 by 61% to 113%, while it decreased PGE2 levels in the pleural exudate by 9% to 71% at 6 hr after dosing. These results suggest that sustained increase of gastric PGE2 by BHB could be responsible for protection against indomethacin-induced gastric mucosal lesions and that BHB is a suitable anti-ulcer agent for NSAIDs without compromising their anti-inflammatory effects.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 药理学
[关键词] Benexate hydrochloride betadex;Gastric mucosa;Indomethacin;Prostaglandin;Pleurisy [时效性] 
   浏览次数:11      统一登录查看全文      激活码登录查看全文